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Abstract: Morquio syndrome is a rare disease caused by a disorder in the storage of mucopolysac-
charides that affects multiple organs, including musculoskeletal, respiratory, cardiovascular, and
digestive systems. Respiratory failure is one of the leading causes of mortality in Morquio patients;
thus, respiratory function testing is vital to the management of the disease. An automated respiratory
assessment methodology using the pneuRIP device and a machine-learning algorithm was developed.
pneuRIP is a noninvasive approach that uses differences between thoracic and abdominal movements
(thoracic-abdominal asynchrony) during respiration to assess respiratory status. The technique was
evaluated on 17 patients with Morquio (9 females and 8 males) between the ages of 2 and 57 years.
The results of the automated technique agreed with the clinical assessment in 16 out of the 17 patients.
It was found that the inverse cumulative percentage representation of the time delay between the
thorax and abdomen was the most critical variable for accurate evaluation. It was demonstrated that
the technique could be successfully used on patients with Morquio who have difficulty breathing with
100% compliance. This technique is highly accurate, portable, noninvasive, and easy to administer,
making it suitable for a variety of settings, such as outpatient clinics, at home, and emergency rooms.
Keywords: automated pulmonary assessment; Morquio syndrome; noninvasive pulmonary diagnos-
tics; thoracic-abdominal asynchrony
1. Introduction
Morquio syndrome (technically termed “mucopolysaccharidosis type IV [MPS IV]”) is
a rare disorder that occurs in 1 out of 200,000 to 300,000 births [1–3]. Individuals with this
disorder have a deficiency of a lysosomal enzyme, either N-acetylgalactosamine-6-sulfate
sulfatase (GALNS; Morquio A) or β-galactosidase (Morquio B) and cannot break down
specific glycosaminoglycans (GAGs). This enzyme deficiency results in the accumulation
of GAGs, keratan sulfate (KS), and/or chondroitin-6-sulfate (C6S) within various tissues,
especially bone, cartilage, and connective tissues, causing progressive damage to multiple
organs. In general, type A comprises the more severe form.
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The disease usually manifests between about 1 and 3 years of age with symptoms
such as kyphosis (hump-back), short neck, cervical spinal cord compression, protrusion of
the chest bone (pectus carinatum), short stature, abnormal waddling gait, or knock knee
(genu valgum), or a combination of these. Patients with MPS IV typically require frequent
orthopedic surgeries of the spine (cervical decompression/fusion), hips (reconstruction
and replacement), legs (osteotomy), knees (8-plate), etc. Cervical decompression/fusion
surgery is required to stabilize their cervical region, prevent spinal compression, and avoid
paraplegia and possible death. Another common cause of death is respiratory problems
including progressive airway narrowing, which is life-threatening with age. An imbalance
of growth, including short neck and stature, adenotonsillar hypertrophy, large mandible, or
pectus carinatum, causes respiratory distress and makes intubation and extubation difficult,
driving challenges in the anesthetic process during surgeries [4].
Standard clinical respiratory measures, such as spirometry, require active effort and
cooperation from patients. Consequently, these tests provide low compliance rates among
children and those with disabilities [5,6]. Thus, proper respiratory assessment with minimal
voluntary effort is a critical need. Furthermore, these conventional techniques involve
collection of expired gases, which may contain infectious viruses and require careful
cleaning techniques. With the recent events due to COVID-19, these issues have drawn
further attention.
In the proposed method, air flow, respiratory rate (RR), tidal volume (Vt), end-tidal
CO2 (ETCO2), heart rate (HR), and pulse oximetry measurements can be obtained by an
integrated pneumotach (PNT) system for simultaneous, real-time, noninvasive measure-
ments.
Respiratory inductance plethysmography (RIP) is a noninvasive method that can be
used to assess respiratory function by recording the rib cage (RC) and abdominal (ABD)
movements during respiration [7,8]. One hundred percent compliance with the RIP nonin-
vasive test was obtained in pilot studies on patients with Morquio syndrome [9], pediatric
patients in the emergency room admitted for asthma [10], infants with bronchopulmonary
dysplasia [11], and neuromuscular patients [12,13].
Respiratory inductance plethysmography assesses respiratory function by measuring
differences in amplitude and synchrony between the thoracic and abdominal movements
during tidal breathing. For healthy individuals, the time delay is near zero because as a
person breathes the motions of the thoracic and abdominal compartments are almost syn-
chronous for efficient gas exchange. The lag between thoracic and abdominal movements
is known as thoracic-abdominal asynchrony (TAA), indicating the severity of pulmonary
dysfunction. Other parameters such as percentage RC (%RC), which is an indication of
the RC contribution to Vt, and the labored breathing index (LBI), which is a measure of
additional respiratory effort due to asynchronous breathing, are other indices computed to
assess TAA [14,15].
Thoracic-abdominal asynchrony measured using RIP has been identified as a clin-
ical diagnostic for many pulmonary diseases such as asthma [10], chronic obstructive
pulmonary disease [16], and neuromuscular disorders and other diseases such as heart
failure and panic disorder [17]. Data from Giordano et al. [10] on pediatric patients in the
emergency department showed that tidal breathing tests measured by the RIP device could
provide objective measures of the severity of asthma. Many studies [18–21] have found
measurements from RC and ABD wall movements to be valuable predictors of obstruc-
tive sleep apnea. Multiple studies [9,22] conducted specifically on patients with Morquio
syndrome compared various pulmonary function testing methods, such as spirometry,
impulse oscillometry system, pneumatography, and RIP, and demonstrated that RIP is a
reliable indicator of respiratory function.
The standard RIP device (Respitrace System, Sensormedics, Yorba Linda, CA, USA)
requires post-processing to assess respiratory function, thus requiring additional effort
by the physician, making it unsuitable for real-time monitoring. In contrast, pneuRIP, a
recently developed device, records RC and ABD movements similar to the standard RIP
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but transmits the data wirelessly to an iPad that also calculates and displays the respiratory
function parameters in real time [13,14]. Similarly to the standard RIP, the pneuRIP records
the movement of the thorax and abdomen using inductive wires embedded in bands
that are placed around the chest and stomach. It then uses fast Fourier transforms to
measure indices such as the phase difference (φ) between the signals, which effectively is
the time delay between the thoracic and abdominal movements. The automated approach
to computing the respiratory parameters reduces the extra effort for physicians in manually
calculating the time delay or merely inferring the TAA by visual inspection of signals.
Using the indices computed by the pneuRIP, significant differences between healthy
and neuromuscular patients were observed via ANCOVA analysis [13]. However, these
analyses used mean values and did not consider the variation over time. If there are changes
in the parameters over time and their distribution could be uniform, bimodal, or have
extreme outliers [13], then the mean estimate will be imprecise. Accurate interpretation
of the breathing patterns, by observing their variability over time and without outlier
bias, is crucial for predicting impending respiratory dysfunction and failure. Hence, a
median-based robust statistic that uses a cumulative frequency metric, specifically the
inverse cumulative percentage (ICP), was developed to assess variation over time [15].
A novel visual representation of ICP identifies the median statistic and provides relative
durations of normal and abnormal breathing in the patient. Pulmonologists found the
graphic display of ICP very useful, intuitive, and easy to interpret [15].
Further, using the ICP parameter, an accurate automated machine learning (ML)
system for the classification of normal and abnormal breathing was developed and pub-
lished [15]. The model was trained using an elastic-net regularization algorithm and with
signals recorded from healthy pediatric volunteers while they were breathing normally and
with a resistive load to simulate abnormal breathing. It was shown that the model assessed
pulmonary dysfunction among children with neuromuscular disorders very successfully
and was consistent with expert pulmonologists’ evaluations [15]. Because people with
Morquio syndrome have small stature with lung capacities similar to those of children, the
same ML model to evaluate respiratory function among subjects with Morquio syndrome
was used.
2. Materials and Methods
2.1. Data Acquisition and Protocol
This study was approved by the Institutional Review Board (IRB) at Nemours/Alfred I.
duPont Hospital for Children, and assent/consent from the subjects and subjects’ guardians
was obtained. All subjects were seated comfortably in a chair/wheelchair and asked to
remain still for the recording duration. A recording session lasted about 3 min.
Each subject’s cardiopulmonary vital signs (air flow, Vt, ETCO2, HR, and oxygen
saturation [SPO2]) were acquired using an integrated PNT system (CO2SMO; Novametrix
Medical Systems, Wallingford, CT, USA) for simultaneous, real-time noninvasive mea-
surements [9]. The CO2SMO Pulse Oximeter [9] measured oxygen saturation levels in the
blood; this is an indirect measure of respiratory function and does not require arterial blood
sampling. The device has a small sensor clipped to the subject’s index finger to measure
HR and blood SPO2.
The pneuRIP method measures changes in the cross-sectional area of the RC and the
ABD during breathing. It consists of two elastic bands, each with an embedded insulated
wire placed around the RC and the ABD forming a coil (Figure 1). A small AC current
passing through the coil generates a self-inductance that oscillates in a cyclic pattern that
tracks changes in the cross-sectional area associated with respiration. The inductive signals
are transmitted wirelessly to the iPad (Apple Inc., Cupertino, CA, USA) (Figure 1), where
the various TAA indices are calculated and displayed. Data were collected for 3 min from
each subject. Raw signals and the Konno–Mead loops [7] were monitored during the
recording to validate good signal quality.
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Figure 1. The pneuRIP device with elastic bands strapped around the RC and ABD of a subject. 
The bands are connected to a box that transmits data to the iPad. 
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Nemours/Alfred I. duPont Hospital for Children. To develop an ML model, a training set 
of pneuRIP recordings was needed. Since Morquio patients have small statures and lung 
capacities comparable with those of children, recordings from healthy children were cho-
sen to train the model. The training data set included recordings from 10 typically devel-
oping subjects (10–17 years) under two different breathing conditions. One was quiet tidal 
breathing and the other was with an added resistive load. The resistive load was added 
to simulate asynchronous breathing encountered during respiratory dysfunction. Re-
sistance was provided by an external bidirectional laminar resistive load (Hans Rudolph, 
Shawnee, KS, USA) 20 cm H2O/L/sec, which was placed in the mouth while the subject 
wore a nose-clip. The resistive load was used because it was easier to administer on chil-
dren. Allen et al. [11] showed that changes in the relative movements of RC and ABD are 
nonspecific to whether there is obstructive (as experienced by the subjects breathing 
through the resistive load) or restrictive lung problems. 
2.2. Computation of the Respiratory Indices 
To assess respiratory function and TAA, multiple indices such as RR, ETCO2, SPO2, 
%RC, LBI, and phase difference (ϕ) were measured. The RR, ETCO2, and SPO2 were meas-
ured using a pulse oximeter, whereas %RC, LBI, and ϕ were calculated from the record-
ings of the RC and ABD movements by the pneuRIP. 
Respiratory rate is the number of breaths per minute, SPO2 is the level of oxygen 
saturation in the blood, and ETCO2 is the amount of carbon dioxide in the exhaled air. The 
CO2SMO monitor provides all these measurements. 
Phase difference (ϕ) is an essential index for identifying TAA; it is the time delay 
between RC and ABD movements (measured in degrees). The phase over the 3 min dura-
tion was characterized as an ICP to represent the frequency of occurrence of each phase 
angle within the data recorded. The plot of ICP is shown in Figure 2; the normal and ab-
normal regions were obtained by plotting the ICP values of the training data. The data 
from healthy subjects are indicated by green, and the data from healthy subjects breathing 
through the resistive load are indicated by orange. 
Figure 1. The pneuRIP device with elastic bands strapped around the RC and ABD of a subject. The
bands are connected to a box that transmits data to the iPad.
Data were recorded from 17 subjects with Type A Morquio syndrome. They were
bet een the ages of 2 and 57 years with an average height of 102.5 cm and a wide range
of clinical severity. Subjects were recruited during a Morquio symposium organized at
Ne ours/ I. ont Hospital for Children. To develop an ML model, a trai ing
set of pneuRIP recordings was needed. Since Morquio pa ients have small statures and
lung apacities comparable with those of child n, ecordings from healt y children were
chosen to train the model. The training data set included recordings from 10 typically
developing subjects (10–17 years) under two different breathing conditions. One was quiet
tidal breathi g and other as with an added resistive load. The resistive load was
added to simulate asy chronous breathing e countered during respi atory dysfunction.
Re istance was provided by an external bidirectional la i i ti l ( s dolph,
Shawnee, KS, USA) 20 cm H2O/ s c, ic s l c i t e outh while the subject
wore a se-cli . The resistive load was used because it was easier to administer on
children. Allen et al. [11] showed that changes in the relative movements of RC and ABD
are nonspecific to whether there is obstructive (as experienced by the subjects breathing
through the resistive load) or restrictive lung problems.
2.2. Computation of the Respiratory Indices
To assess respiratory function and TAA, multiple indices such as RR, ETCO2, SPO2,
%RC, LBI, and phase difference (φ) were measured. The RR, ETCO2, and SPO2 were
measured using a pulse oximeter, whereas %RC, LBI, and φ were calculated from the
recordings of the RC and ABD movements by the pneuRIP.
Respiratory rate is the number of breaths per minute, SPO2 is the level of oxygen
saturation in the blood, and ETCO2 is the amount of carbon dioxide in the exhaled air. The
CO2SMO monitor provides all these measurements.
Phase difference (φ) is an essential index for identifying TAA; it is the time delay
between RC and ABD movements (measured in degrees). The phase over the 3 min
duration was characterized as an ICP to represent the frequency of occurrence of each
phase angle within the data recorded. The plot of ICP is shown in Figure 2; the normal and
abnormal regions were obtained by plotting the ICP values of the training data. The data
from healthy subjects are indicated by green, and the data from healthy subjects breathing
through the resistive load are indicated by orange.
The %RC is a ratio of the absolute amplitude of rib cage signal to the sum of the
absolute amplitudes of the rib cage and abdomen signals. The %RC is an indication of RC
contribution to Vt and is presented as a percent of the combined RC and ABD movements.
The average %RC in normal breathing is close to 50%, indicating that the RC and the ABD
contribute about the same amount to the respiratory Vt [23].
The LBI is a measure of additional respiratory work effort due to asynchronous
breathing [13–15]. The LBI is a ratio that indicates the efficiency of breathing. The numerator
is the “maximum compartmental volume” and is calculated as the sum of the absolute
values of the RC and ABD compartments if they moved in perfect unison. The denominator
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is the Vt, which is the sum of the absolute values of the RC and ABD compartments as
recorded. If RC and ABD signals are in phase (representing synchronous breathing), then
numerator and denominator terms will be similar, and the LBI would be 1.




Figure 2. The figure depicts an ICP phase plot (purple line) for a subject superimposed on normal 
and abnormal breathing areas. The (*) represents the median phase difference value, (x) represents 
the 75th percentile value, and (o) represents the 25th percentile. The orange (abnormal) area is the 
ICP value for subjects breathing asynchronously because of the resistive load, and the green (nor-
mal) area is the ICP value for healthy subjects breathing normally. 
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contribute about the same amount to the respiratory Vt [23]. 
The LBI is a measure of additional respiratory work effort due to asynchronous 
breathing [13–15]. The LBI is a ratio that indicates the efficiency of breathing. The numer-
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ever, a logistic regression algorithm does have high bias and low variance, which was 
offset by the use of elastic-net regularization. The ‘glmnet’ package in R [24] was used to 
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Figure 2. The figure depicts an ICP phase plot (purple line) for a subject superimposed on normal
and abnormal breathing areas. The (*) represents the median phase difference value, (x) represents
the 75th percentile value, and (o) represents the 25th percentile. The orange (abnormal) area is the
ICP value for subjects breathing asynchron usly because of the resistive load, and the green (normal)
area is th ICP value for h althy subject br a hing normally.
2.3. ML Model Training and Classification
An ML model for the automated identificatio of ormal and abnormal TAA patterns
was utilized for patients with Morquio [15]. A logistic regression metho called elastic-net
regularization was used to train the ML model. This classification technique was chosen
because of the small sample size, which limits the complexity of the algorithm. However, a
logistic regression algorithm does have high bias and lo variance, which was offset by
the use of elastic-net regularization. The ‘glmnet’ package in R [24] was used to run the
elastic-net training. The ICP values were considered as the predictors, and the classification
into normal or abnormal was the response variable as shown in Equation (1) below. The
model prediction (ŷ) of normal or abnormal breathing was calculated using a weighted
sum of the predictor variables (xp) as shown in (1).
ŷ = β̂0 + x1 β̂1 + · · ·+ xp β̂p (1)
The optimal bias-variance trade-off was determined empirically using a 10-fold cross
validation run (Figure 3). The model’s performance was evaluated by comparison with an
expert’s judgment. Pulmonary experts evaluated and compared RIP-time measures with
the ICP plots and categorize them as normal or abnormal TAA patter s, and the model’s
classification was co pared with the experts’ categorization. In addition, the model’s
classificati n was also compared with an expert’s opinion of the respirato y function based
on clinical asses ment.
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3.1.4. Percentage Rib Cage (%RC)
Similarly, the average %RC of patients with Morquio was compared with that of
healthy individuals of the same age (Figure 6). The majority of the patients (10 of the 17)
were found to have abnormal %RC.
3.1.5. Labored Breathing Index
Comparing the LBI of patients with Morquio with that of healthy individuals, it was
found that a total of 6 patients with Morquio had LBI values out of the normal range and 4
patients had LBI greater than 20% of the mean value (Figure 7).
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3.1.6. Phase Difference
In mean phase difference (Figure 8), 7 of the 17 subjects were found to have phase
differences above 20% of the healthy population’s mean.
3.1.7. Inverse Cumulative Phase
Instead of looking at just the mean phase, the ICP was computed, and ML modelling
was used to identify abnormal vs. normal breathing among the patients with Morquio
(Table 1).
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3.2. Model Predictions
The elastic-net model’s performance was determined by comparing the model’s
response with the expert’s evaluation [15]. One hundred percent accuracy was obtained
as the model’s prediction exactly matched the human expert’s judgment. Recall that
the models were trained on abnormal breathing patterns generated by healthy subjects
breathing through a resistive load to simulate TAA br athing. At the same time, th
asses men set included r cordings of patie ts with Morquio. Yet, the model pred ctions
on the abnormal breathing patterns ollec ed fro patients with Morquio were excellent.
This indicates th t the method used to simulate TAA breathing was a good representation
of the brea ing patte n of patients with Morquio while in respiratory di tress and that the
training algorithm was ffective in generalizing to a data set from a differ nt population.
3.3. Clinical Diagnosis and Surgeries
A p diatric anesthesiolog st (MT) provided clinical ass sment of the respiratory
functio of e ch of the patients with Morquio (Table 2). Any surgeries related to the neck
or trachea were also noted to observe if that might have an effect on their respiration.
Tracheal narrowing [25] and airway obstruction [26] are known symptoms of patients with
Morquio A syndrome. Tracheal reconstruction surgery [27], which includes tracheal and
vascular reconstruction, is done to relieve tracheal obstruction and also addresses lower
airway obstruction. Pizzaro et al. [27] showed that this surgery resolved a 16-year-old
patient’s respiratory symptoms. Please note that the clinical assessment was given prior to
the tracheal reconstruction surgery.
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Table 2. Clinical assessment of the respiratory function of the patients with Morquio by an anesthe-
siologist and list of surgeries related to the neck and trachea. OSA, obstructive sleep apnea; RAD,
restrictive airway disorder; NA, no medical information was available; “none”, no neck or tracheal
surgery was performed.
Patient ID Clinical Diagnosis Surgery Related to Trachea and CervicalRegions
1 NA Cervical fusion
2 Moderate narrowing of trachea Cervical fusion,tracheal reconstruction surgery
3 OSA, RAD, restrictive lung disease Cervical fusion,tracheal reconstruction surgery
4 NA Cervical fusion
5 No respiratory issues Spinal decompression
6 Severe central airway obstruction Cervical fusion,tracheal reconstruction surgery
7 NA NA
8 Mild central airway obstruction Cervical fusion
9 NA NA
10 Severe central airway obstruction None
11 OSA, mild narrowing of centralairway Tracheal reconstruction surgery
12 Mild OSA, moderate central airwayobstruction Neck fusion
13 Severe central airway obstruction None
14 NA NA
15 Severe central airway obstruction Tracheal reconstruction surgery
16 No respiratory issues Cervical fusion
17 No respiratory issues None
A summary of all the respiratory function variables that were measured is presented
in Table 3; SPO2 is not included since all patients had normal levels. A column for surgery
indicates if the patient had neck/tracheal surgery. The column for clinical diagnosis
indicates if the anesthesiologist’s assessment of the patients’ respiratory function was
normal or abnormal.
Table 3. Subjects with normal and abnormal values for each of the variables measured and the clinical diagnosis are shown
here with 3 representing normal and 5 representing abnormal, “NA” representing unavailable information, and “none”
meaning no surgery related to the neck or the trachea was performed on the patient.
Patient # Age RR ETCO2 %RC LBI Phase ICP (Phase) Surgery Clinical Diagnosis
1 20 5 3 3 3 3 3 3 NA
2 12 5 3 5 3 3 3 3 5
3 22 5 5 5 3 3 3 3 5
4 43 5 3 5 3 3 3 3 NA
5 5 5 NA 3 5 5 3 3 3
6 14 5 3 5 3 5 3 3 5
7 5 3 3 3 5 5 5 NA NA
8 24 5 5 3 3 3 3 3 5
9 40 3 3 3 3 5 3 NA NA
10 15 5 3 5 5 5 5 None 5
11 22 5 3 5 3 3 3 3 5
12 35 5 3 5 3 3 3 3 5
13 9 5 3 5 3 5 5 None 5
14 57 3 5 5 3 3 3 NA NA
15 27 3 3 5 3 3 3 3 5
16 4 3 3 3 3 3 3 3 3
17 2 5 3 3 5 5 5 None 5
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Table 3 shows that there were four patients with abnormal ICP (5 in column 8), and
three of those four patients were diagnosed as having respiratory problems (5 in column
10); information was unavailable for one of them (subject #7). In addition, there were six
other patients who were diagnosed clinically as having respiratory trouble who did not
have abnormal ICP values, and all had tracheal or neck fusion surgeries. It is noteworthy
that all patients who had tracheal/neck surgeries had normal ICP phase.
4. Discussion
There are multiple diagnostic methods available to assess respiratory function; some
are invasive and hard to administer, such as spirometry, and others, such as sleep apnea
tests, are noninvasive but require technicians to administer. However, pneuRIP is noninva-
sive, needs minimal expertise to administer, and requires just about 5 min of the subject’s
time but can also be used for real-time monitoring. One hundred percent compliance
has been shown in all studies [13–15], and, furthermore, both restrictive and obstructive
disorders can be identified with this method [12]. In addition, diagnosing respiratory
dysfunction has been automated using ML modeling [15], making it adaptable to in-home
or any hospital setting, such as the emergency department.
From the results summarized in Table 3, even though all patients had normal blood
oxygen levels, 12 of them had abnormal respiratory rates, and 3 had abnormal ETCO2 levels.
During pulmonary testing, most patients become over conscious of their breathing, and,
sometimes, abnormal RR rates are associated with the emotional aspect of the measurement
process. Of the three patients who had abnormal ETCO2 values, the patient with high
ETCO2 was 57 years old and a long-time smoker (#14); this result is consistent with high
CO2 levels and chronic obstructive lung disease. The testing process, as noted above,
suggests the reason why the two other patients (#3 and #8) had low ETCO2 levels. In the
present study, a significant correlation between RR and ETCO2 levels could not be found;
however, this was a small data set of patients with a rare disease. The sample size was too
small to establish a correlation between these parameters. A correlation between height
and these respiratory parameters was also not observed, since within the sample size the
range of heights was limited (97.8–105.4 cm), with most patients already at their mature
height at the time of the measurements.
Of the three patients with sleep apnea problems and eight with airway obstruction,
one patient (subject #3) had both obstructive sleep apnea (OSA) and airway obstruction.
Thus, there were a total of 10 subjects who had OSA or airway obstruction problems or
both. Only two of them were identified as having abnormal ICP, and these two were
the only ones who did not undergo tracheal reconstruction surgery or a cervical fusion.
The remaining eight subjects who had surgery all had normal ICP phase values. The
neck/tracheal surgeries performed to stabilize the cervical region may indirectly help to
alleviate respiratory stress due to TAA.
Two other subjects, #7 and #17, also had not undergone any tracheal surgeries, prob-
ably because they were young (<15 years old) and were found to have abnormal ICP.
The anesthesiologist found subject #7 to have clinical indications of respiratory problems
consistent with the ICP evaluation. Subject #17 was the only patient who had abnormal
ICP values where the anesthesiologist found no respiratory issues. This might have been
because the subject was only 2 years old, and the analysis is based on data collected from
children above the age of 10 years. Prior work with RIP [23] has found that RC and ABD
motions are stabilized only after 5 years. By including more data from younger age groups
it is hoped that a better assessment for the younger population of patients can be provided
as well.
Thus, the ML algorithm’s identification of abnormal TAA agreed with the clinical
assessment in all but one patient’s respiratory function. A simple algorithm, elastic-net,
was used for the automated classification task because of the small sample size, and yet the
accuracy was high; only one patient’s diagnostic classification did not match the clinical
assessment. The data size was small for ML training; however, it was a large data set for
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a rare disease that occurs in 1 in 200,000 to 300,000 births [1–3]. Further, since the ICP
variable can be used to observe the progression of the patients’ respiratory status over time,
it is ideal for monitoring and managing their respiratory function until they are old enough
to have a surgery. Additionally, with the automated ML modeling, respiratory status can
even be measured at home, and, if the respiratory function deteriorates, the physician can
be alerted.
5. Conclusions
An automated, noninvasive device to evaluate respiratory function was implemented.
It has been shown to be an accurate detection system that matches clinical diagnostic
assessment. In addition, the informative graphical display of the ICP feature along with
RIP-time measures can be used to enhance observation and progression of the respiratory
status of a patient over time. Because of the noninvasive nature of the test, 100% compliance
was obtained from the subjects, and, because of the ease of administering the test and the
automated ML diagnostic evaluation, it can be used in any hospital or home setting.
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